Health

AI ยท 251 companies ยท 438 deals tracked
251 Companies
438 Deals Tracked
AI Sector

Health Companies

Heidi Heidi ๐Ÿ‡ฆ๐Ÿ‡บ You(th) Health Tech You(th) Health Tech ๐ŸŒ Recare Recare ๐Ÿ‡ฉ๐Ÿ‡ช a2z Radiology AI a2z Radiology AI ๐ŸŒ Beacon Biosignals Beacon Biosignals ๐Ÿ‡บ๐Ÿ‡ธ Trialbee Trialbee ๐Ÿ‡ธ๐Ÿ‡ช Indigo Indigo ๐Ÿ‡บ๐Ÿ‡ธ Artios Artios ๐Ÿ‡ฌ๐Ÿ‡ง innovaccer innovaccer ๐Ÿ‡บ๐Ÿ‡ธ Sword Health Sword Health ๐Ÿ‡บ๐Ÿ‡ธ

Latest Deals in Health

Pair Team, an AI-enabled medical group, has acquired Town Square, a social care coordination company, to enhance technology-driven care models for Medicare and Medicaid beneficiaries. This acquisition aims to integrate clinical, behavioral, and social care effectively.
Health Jan 24, 2026
$600M
Isomorphic Labs, a drug-design company spun out of Alphabet, raised $600 million in a Series A funding round led by Thrive Capital, with participation from Google Ventures. This funding aims to leverage AI to revolutionize drug discovery, addressing the inefficiencies of traditional methods that take over a decade and cost more than $2 billion. The company focuses on targeting 'undruggable' diseases, partnering with Eli Lilly and Novartis to tackle challenging cancer mutations.
Investors: Thrive Capital, Google Ventures
Health Jan 23, 2026
$600M
Isomorphic Labs, a drug-design company spun out of Alphabet, secured a $600 million Series A funding round in March 2025, led by Thrive Capital with participation from Google Ventures. The funding aims to revolutionize drug discovery using AI, addressing the inefficiencies of traditional methods that have a 90% failure rate in clinical trials. Partnerships with Eli Lilly and Novartis focus on tackling 'undruggable' diseases like pancreatic and lung cancers, although Isomorphic has yet to advance any drugs to clinical trials as of January 2026.
Investors: Thrive Capital, Google Ventures
Health Jan 23, 2026
$11.88M
Aviwell SAS, a deep-tech animal nutrition company based in Toulouse, has successfully raised โ‚ฌ11 million in a Series A funding round. The investment, led by Blue Revolution Fund, aims to enhance Aviwell's AI-driven microbiome discovery platform, Aneto, which focuses on improving animal health and performance in poultry and aquaculture. The funding will accelerate the development of nature-based solutions, addressing the rising demand for sustainable animal protein production while reducing environmental impact.
Investors: Blue Revolution Fund
Health Jan 23, 2026
$3.24M
Altavo, a medtech startup based in Dresden, Germany, raised โ‚ฌ3 million in Series A2 funding to enhance its AI-based voice rehabilitation solutions. The funding round was led by Novalis Biotech and Beteiligungsmanagement Thรผringen, with participation from several investors including TGFS and HTGF.
Investors: Novalis Biotech, Beteiligungsmanagement Thรผringen, TGFS, HTGF
Health Jan 23, 2026
$2.7M
Cancilico, a Dresden-based AI diagnostics startup focused on blood cancers, has raised โ‚ฌ2.5 million in a seed round to expand commercialization and pursue regulatory pathways for its bone marrow analysis software, Myeloaid. The financing was led by a syndicate including High-Tech Grรผnderfonds (HTGF), TGFS โ€“ Technologiegrรผnderfonds Sachsen, Gedad GmbH, and ROI Verwaltungsgesellschaft.
Investors: High-Tech Grรผnderfonds (HTGF), TGFS โ€“ Technologiegrรผnderfonds Sachsen, Gedad GmbH, ROI Verwaltungsgesellschaft
Health Jan 23, 2026
$82M
Mendra, a newly launched biopharmaceutical company focused on rare diseases, has secured an oversubscribed $82 million Series A funding round. This financing aims to acquire, develop, and commercialize therapies for high-unmet-need indications. The round was co-led by OrbiMed, 8VC, and 5AM Ventures, with additional participation from Lux Capital and Wing VC.
Investors: OrbiMed, 8VC, 5AM Ventures, Lux Capital, Wing VC
Health Jan 23, 2026
Rapid Care Acquires DeepDoc to Expand AI-Powered Medical Record Intelligence
Health Jan 22, 2026
$2.7M
Cancilico, a Dresden, Germany-based AI diagnostics startup specializing in blood cancer, raised โ‚ฌ2.5 million in seed funding. The round was led by a consortium including High-Tech Grรผnderfonds (HTGF), TGFS โ€“ Technologiegrรผnderfonds Sachsen, Gedad GmbH, and ROI Verwaltungsgesellschaft. The company plans to use the funds to accelerate its AI-based diagnostic software.
Investors: High-Tech Grรผnderfonds (HTGF), TGFS โ€“ Technologiegrรผnderfonds Sachsen, Gedad GmbH, ROI Verwaltungsgesellschaft
Health Jan 22, 2026
$250M
Miami-based Openevidence has secured a $250 million Series D funding round, doubling its valuation to $12 billion. The funding, co-led by Thrive Capital and DST Global, aims to enhance its AI platform, which provides evidence-based medical answers to clinicians. With over 10,000 hospitals using the tool, Openevidence reported $100 million in annual revenue and a 30% month-on-month growth, highlighting its critical role in improving patient care.
Investors: Thrive Capital, DST Global
Health Jan 22, 2026
$250M
Miami-based Openevidence has closed a $250 million Series D funding round, doubling its valuation to $12 billion. The funding, co-led by Thrive Capital and DST Global, aims to enhance its AI platform, which serves as a vital tool for physicians by providing evidence-based medical answers. The company has reported over $100 million in annualized revenue and claims that 40%-45% of U.S. physicians use its platform, which has expanded to over 10,000 hospitals nationwide.
Investors: Thrive Capital, DST Global
Health Jan 22, 2026
$12M
One to One Health, a Chattanooga, TN-based provider of employer-sponsored onsite and virtual primary care solutions, raised $12 million in funding led by Frist Cressey Ventures. The funds will support the growing nationwide demand for its advanced primary care model and the continued development of its AI-enabled Intelligent Care Manager.
Investors: Frist Cressey Ventures
Health Jan 22, 2026
$4.4M
Claim Health, a New York City-based company focused on AI-driven revenue operations for post-acute care, has raised $4.4 million in seed funding. The funding round was led by Maverick Ventures, with participation from Peak XV, Y Combinator, and DHVP, along with contributions from C-suite executives at major post-acute care providers. The funds will be used to enhance their services.
Investors: Maverick Ventures, Peak XV, Y Combinator, DHVP
Health Jan 22, 2026
$250M
Openevidence, a US-based company, has raised $250 million in a Series D funding round, valuing the company at $12 billion. The funding, co-led by Thrive Capital and DST Global, will enhance research and computing capacity for its AI-powered medical search engine, which helps doctors quickly access reliable, peer-reviewed medical information. Over 40% of US physicians use the platform, which supported 18 million clinical consultations in December alone, up from 3 million a year prior.
Investors: Thrive Capital, DST Global
Health Jan 22, 2026
$216M
Oviva has raised โ‚ฌ200 million in a Series D funding round to enhance its digital therapy programs for obesity and chronic illnesses, addressing the needs of over 200 million European adults. The funding, sourced from investors including Kinnevik and Planet First Partners, will help expand its offerings into hypertension and type 2 diabetes. The platform integrates a certified medical app with multidisciplinary care teams, providing evidence-based interventions and full reimbursement in Germany, the UK, and Switzerland.
Investors: Kinnevik, Planet First Partners
Health Jan 22, 2026
$4.4M
Claim Health, a Y Combinator-backed startup, has raised $4.4 million in a seed round led by Maverick Ventures, with participation from Peak XV, Y Combinator, and DHVP. The funding aims to modernize revenue operations in post-acute care, addressing the growing demand for efficient workflows in home health, hospice, and personal care settings.
Investors: Maverick Ventures, Peak XV, Y Combinator, DHVP
Health Jan 22, 2026
$12M
One to One Health has secured a $12 million minority growth investment from Frist Cressey Ventures to enhance its employer-sponsored primary care model and expedite the development of its AI-enabled clinical platform, Intelligent Care Manager.
Investors: Frist Cressey Ventures
Health Jan 22, 2026
Rapid Care, an AI-driven healthcare technology company, has acquired DeepDoc, an advanced AI platform for medical record analysis, to enhance its portfolio of AI-enabled solutions. The acquisition aims to automate the organization and synthesis of medical records, improving efficiency and decision-making in healthcare operations. DeepDoc's technology boasts over 99% accuracy in summarizing clinical documentation. This strategic move follows Rapid Care's previous acquisitions and is supported by a team of over 2,200 professionals worldwide.
Health Jan 22, 2026
$250M
Openevidence Inc., a startup focused on developing artificial intelligence software for physicians, has raised $250 million in funding, led by Thrive Capital and DST Global. This funding values the company at $12 billion, significantly increasing its worth since its first funding round last February.
Investors: Thrive Capital, DST Global
Health Jan 21, 2026
$40M
answersnow has raised $40 million in Series B funding led by HealthQuest Capital, with participation from Left Lane Capital and Owl Ventures. The company provides virtual applied behavioral analysis therapy, achieving clinically proven outcomes in significantly fewer hours than traditional methods, resulting in cost savings for payors. The funding will be used to scale operations and enhance AI capabilities to improve personalized therapy for autism support services.
Investors: HealthQuest Capital, Left Lane Capital, Owl Ventures
Health Jan 21, 2026